| Literature DB >> 30723156 |
Adele M Lehane1, Adelaide S M Dennis2, Katherine O Bray2, Dongdi Li2, Esther Rajendran2, James M McCoy3,4, Hillary M McArthur2, Markus Winterberg2, Farid Rahimi2, Christopher J Tonkin3,4, Kiaran Kirk5, Giel G van Dooren6.
Abstract
The Plasmodium falciparum ATPase PfATP4 is the target of a diverse range of antimalarial compounds, including the clinical drug candidate cipargamin. PfATP4 was originally annotated as a Ca2+ transporter, but recent evidence suggests that it is a Na+ efflux pump, extruding Na+ in exchange for H+ Here we demonstrate that ATP4 proteins belong to a clade of P-type ATPases that are restricted to apicomplexans and their closest relatives. We employed a variety of genetic and physiological approaches to investigate the ATP4 protein of the apicomplexan Toxoplasma gondii, TgATP4. We show that TgATP4 is a plasma membrane protein. Knockdown of TgATP4 had no effect on resting pH or Ca2+ but rendered parasites unable to regulate their cytosolic Na+ concentration ([Na+]cyt). PfATP4 inhibitors caused an increase in [Na+]cyt and a cytosolic alkalinization in WT but not TgATP4 knockdown parasites. Parasites in which TgATP4 was knocked down or disrupted exhibited a growth defect, attributable to reduced viability of extracellular parasites. Parasites in which TgATP4 had been disrupted showed reduced virulence in mice. These results provide evidence for ATP4 proteins playing a key conserved role in Na+ regulation in apicomplexan parasites.Entities:
Keywords: ATPase; Na+ pump; TgATP4; Toxoplasma gondii; cipargamin; drug action; malaria; membrane transport; protozoan parasite; sodium transporter
Mesh:
Substances:
Year: 2019 PMID: 30723156 PMCID: PMC6462519 DOI: 10.1074/jbc.RA118.006706
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157